x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

AI For Pharma Growth

Dr Andree Bates

AI For Pharma Growth is the podcast from pioneering Artificial Intelligence entrepreneur Dr. Andree Bates created to help Pharma, Biotech and other Healthcare companies understand how the use of AI-based technologies can easily save them time and grow their brands and company results. This show blends deep experience in the sector with demystifying AI for biopharma execs from biotech start-ups right through to big pharma. In this podcast, Dr Andree will teach you the tried and true secrets to

technology entrepreneurship

All Episodes

37:34

E100 | How Pharma can manage risk with cybersecurity...

AI For Pharma Growth ·

2024/02/14

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Greg Woolf of AI Think Tank to discuss managing cybersecurity risks with AI in the pharmaceutical industry. Greg draws from his experience launching AI companies to discuss the growing $10 trillion cybercrime industry. He addressed threats facing healthcare like ransomware and identity theft exploiting medical data breaches. Greg also covers challenges of reliability, bias and other risks with AI systems. However, he believes AI

en

37:30

E99 | How to use AI to connect meaningfully with...

AI For Pharma Growth ·

2024/02/07

In this episode of AI For Pharma Growth, Dr Andree Bates discusses SQREEM Technologies with Ian Chapman-Banks. SQREEM uses AI to analyse digital behaviours of healthcare professionals, helping pharmaceutical companies better engage this audience. SQREEM has developed advanced algorithms and one of the largest datasets on probabilistic healthcare professional profiles globally. The discussion provides insights into how SQREEM personalised marketing and ad targeting for professional segments. It

en

01:11:34

E98 | How to Use Generative AI models effectively for...

AI For Pharma Growth ·

2024/01/31

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Jonathan Green who is an expert at using artificial intelligence tools to accelerate online business. He is the Best Selling Author of chat GPT Profits, and has a mailing list of over 100,000 subscribers. They talk about how generative AI is revolutionising digital marketing and how it can be used for tasks like content creation, data analysis, and customer engagement. Jonathan discusses how he uses AI tools like chatGPT,

en

44:10

E97 | Predictions about the future of Tech

AI For Pharma Growth ·

2024/01/24

In this episode of AI For Pharma Growth, host Dr Andree Bates interviews Sani Abdul-Jabbar, CEO of VezTek USA, a technology consulting firm. He has over 20 years of experience helping startups bring emerging technologies like AI and blockchain to market faster. He discusses his background and how VezTek supports clients. Sani also shares his insights on recent advancements in machine learning and blockchain, as well as predictions for industries like healthcare, fintech and beyond. In this

en

38:14

E96 | How Generative AI and Web3.0 are...

AI For Pharma Growth ·

2024/01/17

In this episode of AI For Pharma Growth, host Dr Andree Bates talks with Eric McHugh, president of SHOPX, to discuss opportunities at the intersection of generative AI and web3 for pharmaceutical companies. Eric explains how blockchain technologies like non-fungible tokens (NFTs) can help authenticate drugs and medical records to prevent counterfeiting. He also explores how patient data on the blockchain could help AI systems identify new treatment patterns and target drug development. Eric shares

en

41:30

E95 | How pharma R&D can use AI to accelerate...

AI For Pharma Growth ·

2024/01/10

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Casper Wilstrup, founder and CEO of Abzu. They discuss how Abzu's QLattice Explainable AI algorithm can be used to accelerate disease understanding, drug design, and insights in pharma R&D. Casper explains how the QLattice generates hypotheses to explain phenomena using symbolic AI without requiring large datasets. They explore applications in areas like biomarkers, RNA therapeutics, and reducing drug development timelines

en

24:35

E94 | AI for forecasting

AI For Pharma Growth ·

2024/01/03

In this episode of AI For Pharma Growth, Dr Andree Bates speaks with Piet Buyck, CEO and founder of Garvis AI. He talks about how the company's AI system provides significantly more accurate demand forecasting for pharmaceutical companies. Piet explains that Garvis AI leverages different data sources and AI techniques to separately forecast demand for various elements, reducing errors by up to 30% compared to traditional methods. In this episode you will learn: How traditional pharmaceutical

en

42:23

E93 | How to hyperscale your business with enterprise...

AI For Pharma Growth ·

2023/12/27

Dr. Andree Bates interviewed Alexander De Ridder, co-founder and CTO of SmythOS, to discuss how their AI agent platform can help pharmaceutical companies scale up their businesses. Alexander explained that SmythOS allows users to orchestrate intelligent agents that can automate workflows, analyse complex datasets, and augment human work. The agents can collaborate to complete tasks like research, writing, and marketing. By tapping into available AI models and APIs, the agents are able to apply

en

21:08

E92 | How pharma can use AI to do hours worth of...

AI For Pharma Growth ·

2023/12/20

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Saikiran Chandha, founder of SciSpace. Saikiran discusses how SciSpace uses AI to help researchers save time on literature reviews and writing. SciSpace has developed tools using large language models to summarise papers, generate citations, and paraphrase text while maintaining the desired tone. Saikiran explains how researchers can upload their own papers and use SciSpace's AI capabilities on the full text. The discussion

en

17:33

E91 | The state of Ai in biopharma R&D, BD&L and...

AI For Pharma Growth ·

2023/12/13

In this episode of AI For Pharma Growth, Dr Andree Bates talks about the state of AI in biopharma, with a specific focus on how it is being applied across the value chain from research and development to business development, licensing, and clinical trials. She discusses how AI can help accelerate drug discovery by analysing vast amounts of data, generate new drug candidates through machine learning, and help design and optimise clinical trials. Real-world examples of AI being used for COVID drug

en

26:37

E90 | How to use AI to redesign drugs to be faster,...

AI For Pharma Growth ·

2023/12/06

In this episode of AI For Pharma Growth, Dr Andree Bates interviews Alice Yu and Mena Abdelsayed, co-founders of OncoCardia. They discuss how their company uses artificial intelligence and stem cell technology to redesign drugs to be safer and more effective. They aim to reduce the time it takes to develop new drugs from almost a decade to just days or weeks. OncoCardia leverages AI to predict safer drug analogues and their synthesis routes. Their stem cell platform also allows for high

en

24:45

E89 | How to Use AI quickly to engage HCPs and patients

AI For Pharma Growth ·

2023/11/29

In this episode of AI For Pharma Growth Dr Andree Bates is joined by Mark Benthin, Founder, CEO and Executive Chairman of ViiHealth to discuss how AI can be used to quickly engage HCPs and patients through personalising interactions with marketing content. Mark discusses ViiHealth's use of generative AI to create personalised videos for physicians and patients using just one hour of recorded content from the person. He explains how this approach increases engagement rates, click through rates, and

en

30:43

E88 | AI in healthcare policy

AI For Pharma Growth ·

2023/11/22

In this episode of AI For Pharma Growth, host Dr. Andree Bates is joined by guest Dylan Reid, a Legislative Associate focused on health policy. Dylan discusses the current state of AI healthcare policy across various US government organisations. He outlines the FDA approval process, initiatives and committees aimed at balancing innovation and oversight. Additionally, Dylan shares his views on using AI to improve outcomes, particularly in states facing greater challenges. In this episode you will

en

29:40

E87 | How to use Artificial Intelligence to convert...

AI For Pharma Growth ·

2023/11/15

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Mike Kalfus from Graphene AI. Mike discusses his background in data-driven marketing and how he came to work at Graphene AI. He explains how Graphene AI uses natural language processing and machine learning to analyse conversations from a variety of data sources to provide pharmaceutical companies actionable insights. Mike details how Graphene AI can help answer specific questions from pharma clients, such as analysing market

en

17:38

E86 | How pharma can use AI to create accurate...

AI For Pharma Growth ·

2023/11/08

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Phil Gooch, Founder of Scholarcy. They discuss how pharma can use AI to create accurate summaries of scientific documents to help medical professionals save time when reviewing literature. Phil describes how he developed the idea for Scholarcy after struggling himself with reviewing many research papers as a PhD student. He explains how Scholarcy works and how users can access its tools either through the website or by

en

25:22

E85 | Using AI for automating writing of CSRs

AI For Pharma Growth ·

2023/11/01

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Jennifer Bittinger, President of Narrativa. They discuss Narrativa's use of artificial intelligence to automate the writing of clinical study reports and safety reports. Jennifer explains how she joined the company to help expand their AI automation capabilities in North America. She gives a case study of how Narrativa helped reduce the timeline and costs for the Leukaemia and Lymphoma Society's documentation for a clinical

en

37:37

E84 | How to use AI to identify novel drivers of...

AI For Pharma Growth ·

2023/10/24

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Max Dordevic, Co-Founder & CEO at NeuroX1. NeuroX1 is a company that utilises AI to identify and treat neurological diseases that affect millions of people every year. Max discusses how NeuroX1 brings their novel approach to the industry by working diligently to bring viable drug candidates into clinical trials sooner and reinvigorating the pipeline for drug targeting neurological and neuro-oncological diseases. Max provides

en

32:15

E83 | Automating Strategic Literature Reviews with AI

AI For Pharma Growth ·

2023/10/17

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Richard Graves, Chief Commercial Officer & Co-founder at Sorcero, to discuss how AI can be used to generate strategic literature reviews accurately and reduce costs for medical affairs teams. Richard discusses his background in data science and climate science and how his father's cancer diagnosis led him to co-found Sorcero. He explains how their intelligent publication monitoring and literature review tools use AI to

en

23:41

E82 | How to get Artificial Intelligence to help you...

AI For Pharma Growth ·

2023/10/10

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Maddie Bell co-founder & CEO, Scheduler.AI. Scheduler.AI's AI-powered virtual assistant helps schedule meetings effortlessly. Maddie discusses the background of starting Scheduling.AI, how long it took to develop the first version, challenges faced with cultural biases, and future plans to transform enterprises by giving employees back their most valuable commodity - time. In this episode you will learn: Why Scheduler.AI was

en

30:39

E81 | The Future of Leadership and Innovation in Pharma

AI For Pharma Growth ·

2023/10/03

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Adam Kingl to discuss the future of leadership and innovation in pharma. While new technologies are creating medical breakthroughs, they also threaten major revenue decreases for pharma companies. Adam shares how assessing assumptions around customers, offerings, and how value is delivered can spark business model innovation. He emphasises culture change through behaviours that encourage risk-taking and celebrating failures. This

en

202 results

Similar Podcasts

Lead With AI

Tamara Nall

Linux in the Ham Shack

Black Sparrow Media

Data Engineering Podcast

Tobias Macey

Eye On A.I.

Craig S. Smith

Reflections

Livewire Labs